Sanofi, Formation Bio and OpenAI are collaborating to build AI-powered software to accelerate drug development and bring new medicines to patients more efficiently.
Novo Holdings will acquire an approximately 60% controlling stake in Singe Use Support, alongside the two company founders who will each retain 10% and Danaher which will retain 20% of the share capital.
Sharp, a global leader in contract packaging, clinical supply services and small-scale sterile manufacturing, has announced plans for the expansion of its Macungie, PA site in North America to increase its production capacity for sterile injectables.
Cormica, has completed the seven-figure purchase of TPM Laboratories (TPM) in New Jersey. Cormica, backed by Limerston Capital, is focused on strategically expanding its capabilities across the U.S and Europe.
Berry Global Group has invested in additional assets and manufacturing capabilities to increase its healthcare production capacity by up to 30% across three of its European sites.
Kühne Holding AG has entered into a definitive agreement to acquire pharma contract development and manufacturing organisation Aenova Group from leading international investment firm BC Partners.
Takeda have announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO (vedolizumab) subcutaneous administration for maintenance therapy in adults with moderately to severely active Crohn’s disease.
FUJIFILM Corporation have announced an investment of $1.2 billion in its Large-Scale Cell Culture CDMO Business to further expand the planned FUJIFILM Diosynth Biotechnologies end-to-end bio-manufacturing facility in Holly Springs, North Carolina.
BBI Solutions OEM Limited (BBI) has announced the successful closing of the acquisition of IBEX Technologies Inc. (IBEX), a leading developer and manufacturer of high-precision enzymes and diagnostic solutions located in Montréal, Québec.
